Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/UNITY BIOTECHNOLOGY INC/ 8-K

Current Report · 8-K

UNITY BIOTECHNOLOGY INC

Current Report

Filed Sep 19, 2025Accepted Sep 19, 2025, 12:56 PM EDTCIK 1463361Accession 0001193125-25-209210
View company →Permanent SEC source ↗
Share

Company context

Historical securities (1)
UNBXNASDAQ · EQUITY · Historical · closed Oct 1, 2025

Recent company filings

  1. 15-12G filingJan 2, 2026
  2. SCHEDULE 13G/A - filed by ARCH Venture Fund VII, L.P. regarding Unity Biotechnology, Inc.Nov 14, 2025
  3. EFFECT filingSep 26, 2025
  4. EFFECT filingSep 26, 2025
  5. 8-K filingSep 26, 2025

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗